How many studies have been conducted on Virginiamycin?

BiohacksAI has indexed 300 PubMed studies on Virginiamycin, including 15 randomized controlled trials (RCTs). 10% of studies involve human subjects.

What are the main research areas for Virginiamycin?

The primary research domains for Virginiamycin are 🦠 Gut & Microbiome, ⚡ Energy & Fatigue, 🧠 Focus & Attention. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Virginiamycin

A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.

300+ PubMed studies analyzed · 15 RCTs · Evidence Score: 44.8

Research Domains

Virginiamycin has been studied across 10 research domains including 🦠 Gut & Microbiome, ⚡ Energy & Fatigue, 🧠 Focus & Attention, 🫁 Liver & Detox, 🛡️ Immunity. The primary research focus is 🦠 Gut & Microbiome with 16% of studies addressing this area.

Loading evidence profile...

This evidence profile for Virginiamycin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.